Blastomycosis Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Blastomycosis Treatment Market is segmented By Treatment Type (Itraconazole, Amphotericin B), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.
Blastomycosis Treatment Market Size
Market Size in USD
CAGR6.9%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.9% |
| Market Concentration | High |
| Major Players | Janssen, Scynexis Inc, Novartis AG, Marck & Co., Inc., Sun Pharmaceutical Industries Ltd |
please let us know !
Blastomycosis Treatment Market Analysis
The blastomycosis treatment market is estimated to be valued at USD 202 Mn in 2024 and is expected to reach USD 321.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2031.
There is an increasing prevalence of blastomycosis infections globally due to growing environmental pollution and contaminated water bodies. Additionally, development of newer drug molecules and treatment options by major players are expanding access to therapy.